Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
DEI Awards
Innovation Awards
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Subscribe
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
DEI Awards
Innovation Awards
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
addiction
Regulatory
FDA requires label changes to opioid pain meds to clarify risks
The changes come after a public advisory committee meeting that reviewed data from two studies showing serious risks.
Anastassia Gliadkovskaya
Aug 1, 2025 11:31am
Learnings from Indiana's behavioral health system overhaul
Jan 22, 2025 10:01am
Boulder Care taps Teladoc, Quilted executives amid growth spurt
Nov 8, 2024 4:30pm
DOJ slaps $20M opioid prescription penalty on OptumRx
Jul 2, 2024 6:50am
Officials urge buprenorphine uptake following X-Waiver repeal
Jan 24, 2023 6:00pm
Highmark steps up coverage of prescription digital therapies
Oct 24, 2022 7:40am
